Aprea Therapeutics Reports First Quarter 2020 Financial Results and Provides Update on …,

The Company is conducting, supporting and planning multiple clinical trials of eprenetapopt or APR-246: Pivotal Phase 3 MDS Trial—The Company is …, The Company is conducting, supporting and planning multiple clinical trials of eprenetapopt or APR-246: Pivotal Phase 3 MDS Trial—The Company is …, Read More

Scroll to Top